Clinical Trials Logo

Cranial Nerve Disorder clinical trials

View clinical trials related to Cranial Nerve Disorder.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04151082 Recruiting - Clinical trials for Head and Neck Carcinoma

High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors

Start date: October 31, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This phase I/II trial studies the side effect and best dose of steroid therapy (prednisone or methylprednisolone) in improving symptoms of late radiation-associated lower cranial neuropathy in oropharyngeal cancer survivors. Steroid therapy with prednisone or methylprednisolone may help to improve symptoms associated with late radiation-associated lower cranial neuropathy.

NCT ID: NCT03270059 Recruiting - Clinical trials for Metastatic Malignant Neoplasm in the Brain

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Start date: October 6, 2017
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well gadolinium and ferumoxytol magnetic resonance imaging (MRI) work in diagnosing patients with abnormalities in the central nervous system. Diagnostic procedures, such as gadolinium and ferumoxytol MRI, may help find and diagnose abnormalities in the central nervous system.